Discover how intellectual property rights protect exclusive pharmaceutical use and brand names in biotechnology, influencing innovation and market dynamics.

Purchases reflect strong confidence in the scientific differentiation and commercial potential of ateganosineCHICAGO, Dec. 24, 2025 (GLOBE ...

The new Emerson DeltaV PKM library reportedly cuts months from drug development by providing pre-built specification elements ...

The gross proceeds from the offering are expected to be approximately $1.51 million, prior to offering expenses payable by the Company. The Company intends to use the net proceeds from the offering ...

Genesis Space Flight Laboratories launches its Microgravity Research Rideshare Program, making it easier and more affordable ...

Purchases reflect strong confidence in the scientific differentiation and commercial potential of ateganosine CHICAGO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) ...

HANGZHOU — Nestled in the remote mountains of Zhejiang province, Qingyuan county has transformed its lush forests into a ...

The biotech firm focused on fighting breast cancer was recently selected to the prestigious Charles River Cell & Gene Therapy ...

The Goldman Sachs Mid Cap Growth Fund underperformed its benchmark, the Russell Midcap Growth Index (net), during the quarter ...

The FDA is being transformed from an independent regulator into a high-stakes bargaining chip for White House deal-making.

Adding another potential wrinkle to the industry’s work with China is the Biosecure Act, a piece of China-targeting national ...